{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:47:20Z","timestamp":1791193640784,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.cardfail.2013.01.001","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T12:06:29Z","timestamp":1359979589000},"page":"87-93","source":"Crossref","is-referenced-by-count":41,"title":["Diminished Global Arginine Bioavailability as a Metabolic Defect in Chronic Systolic Heart Failure"],"prefix":"10.1016","volume":"19","author":[{"given":"W. H. Wilson","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeneng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Troughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley L.","family":"Hazen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2013.01.001_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1440-1681.2008.04901.x","article-title":"Constitutive nitric oxide synthases in the heart from hypertrophy to failure","volume":"35","author":"Loyer","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.RES.0000047506.52381.90","article-title":"Reduced myocardial and systemic L-arginine uptake in heart failure","volume":"91","author":"Kaye","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2013.01.001_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2013.01.001_bib4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jacc.2003.08.046","article-title":"Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function","volume":"43","author":"Troughton","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jcem-63-1-72","article-title":"Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma","volume":"63","author":"Yandle","year":"1986","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cardfail.2013.01.001_bib6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1210\/jc.76.4.832","article-title":"Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure","volume":"76","author":"Yandle","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cardfail.2013.01.001_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.amjcard.2007.08.038","article-title":"Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure","volume":"101","author":"Tang","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib8","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.jacc.2007.02.053","article-title":"Prognostic value and echocardiographic determinants of plasma myeloper oxidase levels in chronic heart failure","volume":"49","author":"Tang","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.amjcard.2005.03.055","article-title":"Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in\u00a0systolic left ventricular heart failure (from the ADEPT study)","volume":"96","author":"Troughton","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib10","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2007.01.078","article-title":"Tissue Doppler imaging a new prognosticator for cardiovascular diseases","volume":"49","author":"Yu","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2013.01.001_bib12","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2009.02.036","article-title":"Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk","volume":"53","author":"Tang","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.atherosclerosis.2011.04.041","article-title":"Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography","volume":"218","author":"Sourij","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cardfail.2013.01.001_bib14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jacc.2011.12.022","article-title":"Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1","volume":"59","author":"Shao","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/01.CIR.93.6.1087","article-title":"Expression of inducible nitric oxide synthase in human heart failure","volume":"93","author":"Haywood","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.01.001_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/niox.1997.0150","article-title":"Mechanisms of nitrate accumulation in plasma during pacing-induced heart failure in conscious dogs","volume":"1","author":"Bernstein","year":"1997","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.cardfail.2013.01.001_bib17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0002-9149(01)01894-X","article-title":"Plasma nitric oxide level in heart failure secondary to left ventricular diastolic dysfunction","volume":"88","author":"Yu","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00380-003-0715-y","article-title":"High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: role in reduction of plasma nitric oxide level","volume":"18","author":"Saitoh","year":"2003","journal-title":"Heart Vessels"},{"key":"10.1016\/j.cardfail.2013.01.001_bib19","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1073\/pnas.0506589103","article-title":"Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism","volume":"103","author":"Steppan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cardfail.2013.01.001_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cardfail.2003.09.007","article-title":"PET abnormalities in patients with nonischemic cardiomyopathy","volume":"10","author":"O\u2019Neill","year":"2004","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2013.01.001_bib21","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00109-010-0679-1","article-title":"Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure","volume":"88","author":"Piao","year":"2010","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.cardfail.2013.01.001_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cardiores.2007.05.012","article-title":"Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species","volume":"75","author":"Redout","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2013.01.001_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1164\/rccm.201003-0335OC","article-title":"Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats","volume":"182","author":"Bogaard","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cardfail.2013.01.001_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijcard.2007.07.166","article-title":"Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure","volume":"125","author":"Tatli","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2013.01.001_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/01.CIR.98.2.132","article-title":"Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy","volume":"98","author":"Fukuchi","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2013.01.001_bib26","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1111\/j.1464-5491.2012.03743.x","article-title":"Multifactorial risk factor intervention in patients with type 2 diabetes improves arginine bioavailability ratios","volume":"29","author":"Tripolt","year":"2012","journal-title":"Diabet Med"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641300002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191641300002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T21:27:08Z","timestamp":1539898028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107191641300002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S107191641300002X"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2013.01.001","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}